Provided by Tiger Trade Technology Pte. Ltd.

Viridian Therapeutics, Inc.

28.06
-0.2900-1.02%
Volume:418.46K
Turnover:11.68M
Market Cap:2.87B
PE:-8.44
High:28.26
Open:27.84
Low:27.50
Close:28.35
52wk High:34.29
52wk Low:9.90
Shares:102.21M
Float Shares:102.00M
Volume Ratio:0.32
T/O Rate:0.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3245
EPS(LYR):-3.3245
ROE:-49.16%
ROA:-27.67%
PB:4.86
PE(LYR):-8.44

Loading ...

Wells Fargo Sticks to Their Hold Rating for Viridian Therapeutics (VRDN)

TIPRANKS
·
Mar 02

Truist Financial Sticks to Their Buy Rating for Viridian Therapeutics (VRDN)

TIPRANKS
·
Feb 27

Analysts’ Top Healthcare Picks: Heron Therapeutics (HRTX), Viridian Therapeutics (VRDN)

TIPRANKS
·
Feb 27

Viridian Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Feb 27

Viridian Therapeutics Q4 revenue misses analyst expectations

Reuters
·
Feb 26

Viridian posts FY 2025 net loss of USD 342.6 million

Reuters
·
Feb 26

BRIEF-Viridian Therapeutics Q4 Revenue USD 132 Thousand Vs. IBES Estimate USD 12.7 Million

Reuters
·
Feb 26

Viridian Therapeutics Q4 EPS USD -1.08 VS. Ibes Estimate USD -1.07

THOMSON REUTERS
·
Feb 26

Viridian Therapeutics: IF Both Veligrotug, Elegrobart Are Approved, Co Expects Current Business Plans to Be Funded Through Profitability

THOMSON REUTERS
·
Feb 26

Viridian Therapeutics Q4 Revenue USD 132 Thousand VS. Ibes Estimate USD 12.7 Million

THOMSON REUTERS
·
Feb 26

Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2025 Financial Results

THOMSON REUTERS
·
Feb 26

High Growth Tech Stocks In The US February 2026

Simply Wall St.
·
Feb 12

Viridian Therapeutics Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Feb 03

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Demant (OtherWILLF), Viridian Therapeutics (VRDN) and Tenet Healthcare (THC)

TIPRANKS
·
Feb 03

Exploring High Growth Tech Stocks In The US Market

Simply Wall St.
·
Jan 26

Did FDA Priority Review and EU Push for Thyroid Eye Drug Just Shift Viridian Therapeutics' (VRDN) Investment Narrative?

Simply Wall St.
·
Jan 18

Viridian Therapeutics Grants Stock Options to New Employee as Inducement

Reuters
·
Jan 09

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jan 09

Viridian Therapeutics Inc : UBS Initiates Coverage With Buy Rating and Target Price $50

THOMSON REUTERS
·
Jan 07

Viridian Therapeutics Inc - Veligrotug Bla Accepted for Ted With Pdufa Date June 30, 2026

THOMSON REUTERS
·
Jan 06